Iron Mountain (IRM)
NYSEReal EstateReit - SpecialtySnapshot 2026-07-07
$115.84-0.46%
Close 2026-07-07 · 1-day change
Reading IRM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track IRM free→NYSEReal EstateReit - SpecialtySnapshot 2026-07-07
Reading IRM? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track IRM free→QuarterlyIQ Insights · IRM
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 5 valuation methods, at three horizons. Current price $115.84. As of 2026-07-08. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
A long-thesis check that carries the widest uncertainty of the three horizons.
Above average on quality vs scored peers
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $116 IRM trades at 33× p/ffo — 2.0× the 16× p/ffo peer median. The market is re-rating it beyond its own range; our $71 fair value is low-confidence here. Even the durable-growth case — current growth held at sustainable margins — values it at about $91, at or below today's price, so you're paying beyond even the growth case. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Cheaper than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2025-Q3, 2026-Q1
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| ddm gordon | 12M | $17.65 | — | — | TTM | medium |
| Peer P/FFO | 12M | $57.15 | 16.2 | 3.53 | TTM | medium |
| Peer P/S | 12M | $192.43 | 7.9 | 24.25 | TTM | medium |
| Own P/E history | 12M | $131.46 | 43.7 | 3.01 | TTM | medium |
| triangulated | 12M | $49.36 | 16.2 | 3.05 | Triangulated | medium |
| Peer P/FFO | 3Y | $45.04 | 16.2 | 2.78 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $259.64 | 7.9 | 32.71 | guidance | medium |
| Own P/E history | 3Y | $103.43 | 43.7 | 2.37 | Analyst | medium |
| Peer P/FFO | 5Y | $38.43 | 16.2 | 2.38 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $304.78 | 7.9 | 38.40 | guidance | high |
| Own P/E history | 5Y | $88.15 | 43.7 | 2.02 | Analyst | high |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.